Study of Difluprednate in the Treatment of Inflammation Following Ocular Surgery (ST-601A-002a)

Summary

The purpose of this phase III study is to determine the efficacy of difluprednate in the treatment of inflammation following ocular surgery.

Timeline

Start

—

Primary completion

—

Completion

—

Outcome

Met primary endpoint

registry Difluprednate 0.05% QID vs Placebo; p = 0.0014; Mantel Haenszel NCT00429923 ↗

Publications

• Korenfeld MS, Silverstein SM, Cooke DL, Vogel R, Crockett RS; Difluprednate Ophthalmic Emulsion 0.05% (Durezol) Study Group. Difluprednate ophthalmic emulsion 0.05% for postoperative inflammation and pain. J Cataract Refract Surg. 2009 Jan;35(1):26-34. doi: 10.1016/j.jcrs.2008.09.024.

Drugs

Indications

No indication recorded.